Putting a Face on EDC
Recent legislative and regulatory changes increase the country's appeal as a destination for research.
Patient Power
Advancing medicine and the clinical research process with the help of patient organizations
Transparency Shapes Pharmaceutical R&D
Reformers seek disclosure of investigator payments and conflicts of interest.
Poll Finds Ironic Inefficiency
Uncovering the risky communication methods of clinical trials professionals, while discovering a potential Web-based replacement.
Closer to Transparency
London conference underscores foggy climate surrounding clinicaltrials.gov
Is Clinical Research Recession Proof?
Drug development, largely immune to past economic downturns, now faces a different climate.
Managing Content in 2009
On the scene with electronic content management.
Eliminate the Disconnect in a Systems Approach
Improving the quality and speed of drug development through integration and interoperability.
What I Learned as a Subject
A clinical trials professional with personal experience as a trial subject discusses the purpose and importance of following protocol.
Risk Response: Constructing a Plan
Overcoming hurdles in subject enrollment by managing potential risks in six critical key areas.
EU-Born HIV Study: History in the Making
Ten-year-old study sets precedent for future collaborative observational studies on drug safety.
eClinical Software: March 2009
The latest eclinical software in the clinical trials industry.
Business and People Update March 2009
Industry news focusing on the people and organizations who work in the clinical trials profession.
